Deutsche Bank Raises Price Target on Onyx Pharmaceuticals (ONXX); Adding M&A Scenario
Tweet Send to a Friend
Deutsche Bank maintains a 'Buy' on Onyx Pharmaceuticals (NASDAQ: ONXX) price target of $77.00 (from $58.00).
Deutsche analyst said ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Deutsche analyst said ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
